Publications

Recent publications

  • Development of a patient-derived glioblastoma model in the transgenic Rag2 Null rat: In vivo imaging, histology, and combination therapy assessment.” Cancer Research 82.12_Supplement (2022): 1661-1661
  • Novel therapeutics and drug-delivery approaches in the modulation of glioblastoma stem cell resistance.” Therapeutic Delivery (2022) 13(4), 249–273.
  • Nanoemulsions: An Emerging Technology in Drug Delivery, In Emerging Technologies for Nanoparticle Manufacturing, pp. 381-393, 2021, Chapter 17, Springer, Switzerland, https://doi.org/10.1007/978-3-030-50703-9_17
  • Development of CD133 targeting multi-drug polymer micellar nanoparticles for glioblastoma – in vitro evaluation in glioblastoma stem cells, Pharmaceutical Research. 2021 Jun 7:1-13
  • Aerosolized In Vivo 3D Localization of Nose-to-Brain Nanocarrier Delivery Using Multimodality Neuroimaging in a Rat Model—Protocol Development. Pharmaceutics. 2021 Mar;13(3):391
  • Special focus issue on drug delivery strategies for the treatment of cancer. Therapeutic delivery. 2020 Oct;11(10):605-7
  • Polymeric micelles for anticancer drug delivery. Therapeutic Delivery. 2020 Oct;11(10):613-35
  • Surface Modification Strategies in Enhancing Systemic Delivery Performance. In Systemic Delivery Technologies in Anti-Aging Medicine: Methods and Applications (pp. 365-392). Chapter 15, 2020, Springer, Cham, Switzerland, https://doi.org/10.1007/978-3-030-54490-4_15
  • Development of Biodegradable Polymeric Nanoparticles for Systemic Delivery. In Systemic Delivery Technologies in Anti-Aging Medicine: Methods and Applications (pp. 155-186), 2020, Chapter 7, Springer, Cham, Switzerland, https://doi.org/10.1007/978-3-030-54490-4_6

Recent presentations

  • Antibody targeted multifunctional lipid-polymer nanoparticles loaded with Temozolomide and 89Zr labeled for theranostic of glioblastoma, Annual Meeting of American Association of Pharmaceutical Scientists, virtual, November 2020
  • CD133+ Stem Cell Targeted Dual Drug Nanocarriers For Treatment Of Glioblastoma, 2020 Controlled Release Society Annual Meeting & Exposition, June 27-July 1, 2020, Las Vegas, Nevada, USA
  • Efficacy of ethanol injection as a low temperature, mechanical stress free method to prepare docetaxel folate targeted liposomes, Annual Meeting of American Association of Pharmaceutical Scientists, San Antonio, TX, November 2019
  • Translational Approach to Drug Delivery: Co-administration of CCND1 Targeted siRNA Liposomes with Cisplatin in Mantle Cell Lymphoma Cell Line, Jeko-1, Annual Meeting of American Association of Pharmaceutical Scientists, Washington DC, November 2018.  Invited for the Rapid-Fire podium session for hot topics
  • Cell penetrating peptide enhances therapeutic efficacy of paclitaxel nanomicelles in traditional monolayer culture as well as in multicellular tumor spheroids of triple negative breast cancer, Annual Meeting of American Association of Pharmaceutical Scientists, Washington DC, November 2018.  Best Abstract Award Winner
  • Smart Therapy: Using CCND1 Targeted siRNA Loaded Liposomes to Sensitize Mantle Cell Lymphoma Cells to Cisplatin, Annual Meeting of American Association of Cancer Research, Chicago, IL, April 2018
  • Comparing 2D and 3D Culture Models for In-vitro Therapeutic Screening of Paclitaxel Loaded Micelles Co-administered with iRGD Peptide, Annual Meeting of American Association of Cancer Research, Chicago, IL, April 2018.
  • Docetaxel loaded PLGA-PEG-NH2 nanoparticles conjugated with hyaluronic acid cause enhanced cytotoxicity in MDA-MB-231 cells when co-administered with iRGD peptide, Annual Meeting of American Association of Pharmaceutical Scientists, San Diego, CA, November 2017; AAPS Award for Majumder